πŸ‡ΊπŸ‡Έ FDA
Patent

US 6849621

Piperidine compounds

expired A61PA61P1/00A61P1/04

Quick answer

US patent 6849621 (Piperidine compounds) held by Pharmacopeia Drug Discovery, Inc. expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Pharmacopeia Drug Discovery, Inc.
Grant date
Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61P, A61P1/00, A61P1/04, A61P11/00, A61P25/00